These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6769122)

  • 1. In vivo or in vitro treatments with anti-I-J alloantisera abolish immunity to AKR leukemia.
    Meruelo D; Flieger N; Smith D; McDevitt HO
    Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2178-82. PubMed ID: 6769122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of H-2-linked immune responses involved in resistance to AKR tumor growth.
    Zalman MA; Meruelo D
    Immunogenetics; 1986; 24(1):51-62. PubMed ID: 2874112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The generation and specificity of cytotoxic T cells raised against syngeneic tumor cells bearing AKR/Gross murine leukemia virus antigens.
    Green WR; Nowinski RC; Henney CS
    J Exp Med; 1979 Jul; 150(1):51-66. PubMed ID: 109575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control.
    Green WR
    J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AKR/J gene(s) unlinked to H-2 determines dominant inheritance of lymphocyte hyporesponsiveness to acetylcholine receptor.
    Gorzynski TJ; Lennon VA; Nathanson RM; David CS
    J Immunol; 1985 Apr; 134(4):2079-83. PubMed ID: 3919088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukemia prevention and long-term survival of AKR mice transplanted with MHC-matched or MHC-mismatched bone marrow.
    Longley RE; Good RA
    Cell Immunol; 1986 Sep; 101(2):476-92. PubMed ID: 2944611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
    Green WR
    J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation in MHC antigenic profiles of tumor cells and its biological effects.
    Festenstein H; Schmidt W
    Immunol Rev; 1981; 60():85-127. PubMed ID: 6171505
    [No Abstract]   [Full Text] [Related]  

  • 9. Expression of antigens coded in murine leukemia viruses on thymocytes of allogeneic donor origin in AKR mice following syngeneic or allogeneic bone marrow transplantation.
    Wustrow TP; Good RA
    Cancer Res; 1985 Dec; 45(12 Pt 1):6428-35. PubMed ID: 2998600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
    Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
    J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic control of cell-mediated responsiveness to an AKR tumor-associated antigen: mapping of the locus involved to the I region of the H-2 complex.
    Meruelo D; Deak B; McDevitt HO
    J Exp Med; 1977 Nov; 146(5):1367-79. PubMed ID: 411874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The putative I-Jk- strain AKR/J synthesizes I-Jk+ molecules: implications for Jt gene control of I-J expression.
    Flood PM; Murphy DB
    J Mol Cell Immunol; 1985; 2(2):95-103. PubMed ID: 2978460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of a soluble suppressor factor(s) in the serum of AKR mice bearing lymphocytic leukemia.
    Simon JD; Freed BM; Davignon D; Albala MM
    Cell Immunol; 1983 Nov; 82(1):163-73. PubMed ID: 6605807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-mediated anti-tumor response in the RLmale 1 system. II. Control of the T killer cells by an H-2-linked Ir gene interfering with non-H-2 factors.
    Duprez V; Belucchi S; Lévy JP
    Eur J Immunol; 1980 Jan; 10(1):26-30. PubMed ID: 6767612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential leukemic cells among bone marrow cells of young AKR/J mice.
    Haran-Ghera N
    Proc Natl Acad Sci U S A; 1980 May; 77(5):2923-6. PubMed ID: 6967216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemogenesis, immune responsiveness, and murine leukemia virus expression in congenic AKR/J mice differing at H-2.
    Johnson DA; Bedigian HG; Cherry M; Meier H
    Infect Immun; 1980 Sep; 29(3):1007-12. PubMed ID: 6253394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformation.
    Hui K; Grosveld F; Festenstein H
    Nature; 1984 Oct 25-31; 311(5988):750-2. PubMed ID: 6333639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genes of the H-2 complex regulate the antibody response to murine leukemia virus.
    Vlug A; Schoenmakers HJ; Melief CJ
    J Immunol; 1981 Jun; 126(6):2355-60. PubMed ID: 6262410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquisition of immunogenicity by AKR leukemic cells following DNA-mediated gene transfer is associated with the reduction of constitutive reactive superoxide radicals.
    Chia KY; Lim SP; Oei AA; Sabapathy TK; Hui KM
    Int J Cancer; 1994 Apr; 57(2):216-23. PubMed ID: 8157360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.